MedTrace Logo

Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)

NCT00844129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2018-05-03

No results posted yet for this study

Summary

The purpose of this study is to determine the incidence and clinical history of neurofibromatosis type 1-related spinal abnormalities.

Conditions

  • Neurofibromatosis Type 1

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • University of Utah

    lead OTHER

Principal Investigators

  • David Viskochil, MD, PhD · Division of Medical Genetics, Department of Pediatrics, University of Utah

Eligibility

Min Age
6 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00844129 on ClinicalTrials.gov